Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FGFR2 and favorable survival outcomes in resected poorly cohesive cell gastric cancer: Analysis from FGFR2 protein overexpression and genetic variation.

PloS one - 1 Jan 2026

Lee Yun Ji, Jung Inuk, Baek Jin Ho, Kim Jong Gwang, Park Ki Bum, Park Ji Yeon, Kwon Oh Kyoung, Seo An Na, Kim Moonsik, Kang Byung Woog

Abstract excerpt

PURPOSE: Poorly cohesive cell gastric cancer has aggressive and heterogeneous characteristics. This study investigated the clinical significance of fibroblast growth factor receptor 2 expression and genetic variations in patients with PCC-GC. MATERIALS AND METHODS: We retrospectively collected 209 surgically resected stage II and III PCC-GC cases. After FGFR2 immunostaining, we analyzed clinical data and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gastrectomy

Share to Gene Expression Regulation, Neoplastic

Share to Neoplasm Staging

Share to Receptor, Fibroblast Growth Factor, Type 2

Share to Stomach Neoplasms

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 42224189
DOI: 10.1371/journal.pone.0349408
PMCID: PMC13225409

Genes

FGFR2
GC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FGFR2 and favorable survival outcomes in resected poorly cohesive cell gastric cancer: Analysis from FGFR2 protein overexpression and genetic variation.PMID 42224189Read ↗

FGFR2 overexpression and compromised survival in diffuse-type gastric cancer in a large central European cohortSemantic proximity Read ↗

FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre studySemantic proximity Read ↗

Molecular profile of poorly cohesive gastric carcinoma with special reference to survival.Semantic proximity Read ↗

FGFR2 in gastric cancer: protein overexpression predicts gene amplification and high H-index predicts poor survival.Semantic proximity Read ↗

A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets.Semantic proximity Read ↗

High expression of fibronectin 1 indicates poor prognosis in gastric cancerSemantic proximity Read ↗

Circulating Tumor DNA Analysis Detects FGFR2 Amplification and Concurrent Genomic Alterations Associated with FGFR Inhibitor Efficacy in Advanced Gastric CancerSemantic proximity Read ↗

Acquired FGFR2 mutation leads resistance to pemigatinib in a patient with FGFR2-driven Borrmann type IV gastric cancer.Semantic proximity Read ↗

Cancer-associated fibroblast-derived fibulin-5 promotes epithelial–mesenchymal transition in diffuse-type gastric cancer via cAMP response element-binding protein pathway, showing poor prognosisSemantic proximity Read ↗

Histogenetic insights and genetic landscape of fibromatosis-like undifferentiated gastric carcinoma: a focused study.Semantic proximity Read ↗

FGFR2 gene amplification and clinicopathological features in gastric cancerSemantic proximity Read ↗

HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.